Literature DB >> 33122056

A critical appraisal of clinical practice guidelines for the treatment of lumbar spinal stenosis.

David B Anderson1, Katie De Luca2, Rikke K Jensen3, Jillian P Eyles4, James M Van Gelder5, Jana L Friedly6, Christopher G Maher7, Manuela L Ferreira4.   

Abstract

OBJECTIVE: The aim of the review was to appraise clinical practice guidelines and their recommendations for the treatment of lumbar spinal stenosis.
METHODS: PubMed, Medline, CINAHL, Embase, and Cochrane Central Register of Controlled Trials were searched up until 25/01/2020 for clinical practice guidelines on the management of lumbar spinal stenosis with a systematic process to generate recommendations and were publicly available.
RESULTS: Ten guidelines were included, with a total of 76 recommendations for the treatment of lumbar spinal stenosis. Only 4 of the 10 guidelines were of satisfactory methodological quality according to the AGREE II instrument. Around three-quarters of recommendations (72.4%) were presented with poor evidence, with the remaining 21 presenting (27.6%) fair evidence. No recommendation presented good evidence. Recommendations were made on four types of interventions: surgery, injections, medications, and other nonsurgical treatments, with supporting evidence similar for all four treatment types. Positive recommendations were more common for injections (12/13=92.3%) and surgery (10/15=66%) than for nonsurgical treatments (6/21=28.6%) or medications (1/27=3.75%).
CONCLUSIONS: Ten guidelines on the management of lumbar spinal stenosis were identified in the systematic review, but only four were of adequate methodological quality. While the evidence underpinning the various types of interventions was similar, guidelines tended to endorse surgery and injections but not nonsurgical interventions and medicines. These results support the need for greater rigor and inclusion of steps to minimize bias in the production of guidelines.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AGREE II; Low back pain; Lumbar spinal stenosis; Practice guidelines; Surgery

Mesh:

Year:  2020        PMID: 33122056     DOI: 10.1016/j.spinee.2020.10.022

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  5 in total

1.  More than one third of clinical practice guidelines on low back pain overlap in AGREE II appraisals. Research wasted?

Authors:  Silvia Gianola; Silvia Bargeri; Michela Cinquini; Valerio Iannicelli; Roberto Meroni; Greta Castellini
Journal:  BMC Med Res Methodol       Date:  2022-07-05       Impact factor: 4.612

2.  Supervised physical therapy versus surgery for patients with lumbar spinal stenosis: a propensity score-matched analysis.

Authors:  Masakazu Minetama; Mamoru Kawakami; Masatoshi Teraguchi; Yoshio Enyo; Masafumi Nakagawa; Yoshio Yamamoto; Sachika Matsuo; Tomohiro Nakatani; Nana Sakon; Yukihiro Nakagawa
Journal:  BMC Musculoskelet Disord       Date:  2022-07-11       Impact factor: 2.562

3.  Consensus on a standardised treatment pathway algorithm for lumbar spinal stenosis: an international Delphi study.

Authors:  Christine Comer; Carlo Ammendolia; Michele C Battié; André Bussières; Jeremy Fairbank; Andrew Haig; Markus Melloh; Anthony Redmond; Michael J Schneider; Christopher J Standaert; Christy Tomkins-Lane; Esther Williamson; Arnold Yl Wong
Journal:  BMC Musculoskelet Disord       Date:  2022-06-08       Impact factor: 2.562

Review 4.  Systematic review of guideline-recommended medications prescribed for treatment of low back pain.

Authors:  Morgan R Price; Zachary A Cupler; Cheryl Hawk; Edward M Bednarz; Sheryl A Walters; Clinton J Daniels
Journal:  Chiropr Man Therap       Date:  2022-05-13

Review 5.  The Prevalence of Sarcopenia and Its Impact on Clinical Outcomes in Lumbar Degenerative Spine Disease-A Systematic Review and Meta-Analysis.

Authors:  Wei-Ting Wu; Tsung-Min Lee; Der-Sheng Han; Ke-Vin Chang
Journal:  J Clin Med       Date:  2021-02-15       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.